High enhancer activity is an epigenetic feature of HPV negative atypical head and neck squamous cell carcinoma.
Saved in:
| Title: | High enhancer activity is an epigenetic feature of HPV negative atypical head and neck squamous cell carcinoma. |
|---|---|
| Authors: | Callahan SC; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Kochat V; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States., Liu Z; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Raman AT; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Graduate Program in Quantitative Sciences, Baylor College of Medicine, Houston, TX, United States.; Epigenomics Program, Broad Institute of MIT and Harvard, Cambridge, MA, United States., Divenko M; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States., Schulz J; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States., Terranova CJ; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ghosh AK; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States., Tang M; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, United States., Johnson FM; The University of Texas Graduate School of Biomedical Sciences, Houston, TX, United States.; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Wang J; The University of Texas Graduate School of Biomedical Sciences, Houston, TX, United States.; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Skinner HD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Department of Radiation Oncology, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, PA, United States., Pickering CR; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; The University of Texas Graduate School of Biomedical Sciences, Houston, TX, United States., Myers JN; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; The University of Texas Graduate School of Biomedical Sciences, Houston, TX, United States., Rai K; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States.; The University of Texas Graduate School of Biomedical Sciences, Houston, TX, United States. |
| Source: | Frontiers in cell and developmental biology [Front Cell Dev Biol] 2022 Jul 19; Vol. 10, pp. 936168. Date of Electronic Publication: 2022 Jul 19 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101630250 Publication Model: eCollection Cited Medium: Print ISSN: 2296-634X (Print) Linking ISSN: 2296634X NLM ISO Abbreviation: Front Cell Dev Biol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
